Bridgebio Pharma, Inc. · NASDAQ:BBIO
Ellis Andrea received 3,990 Bridgebio Pharma, Inc. shares as an award (Form 4)
Traded Jun 22, 2026 · Filed Jun 24, 2026
On Jun 22, 2026, Ellis Andrea (Director) received 3,990 Bridgebio Pharma, Inc. shares as an award, leaving 22,579 shares. Filed Jun 24, 2026 (Form 4).
- Awarded
- 3,990 shares
- Holding after
- 22,579 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Award | 3,990 | 22,579 | Direct |